IL6 and atherosclerosis: These data are consistent with the literature in which IL-6 is described as a proinflammatory cytokine canonically upregulated in the senescence-associated secretory phenotype of cells that have undergone stress-induced or replicative senescence [49] and proposed as a serum marker of atherosclerosis [15,50].